ALIROCUMAB for Hypercholesterolaemia: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 4,924 adverse event reports in the FDA FAERS database where ALIROCUMAB was used for Hypercholesterolaemia.
Most Reported Side Effects for ALIROCUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 1,571 | 6.9% | 1 | 79 |
| Product dose omission | 1,354 | 5.9% | 1 | 63 |
| Injection site pain | 1,220 | 5.3% | 4 | 34 |
| Muscle spasms | 1,113 | 4.9% | 2 | 35 |
| Arthralgia | 993 | 4.3% | 3 | 50 |
| Fatigue | 922 | 4.0% | 6 | 69 |
| Pain | 892 | 3.9% | 2 | 76 |
| Pain in extremity | 888 | 3.9% | 1 | 58 |
| Product dose omission issue | 864 | 3.8% | 0 | 30 |
| Injection site bruising | 821 | 3.6% | 2 | 26 |
| Device issue | 785 | 3.4% | 0 | 23 |
| Influenza like illness | 778 | 3.4% | 0 | 23 |
| Diarrhoea | 738 | 3.2% | 1 | 82 |
| Headache | 718 | 3.1% | 1 | 61 |
| Injection site erythema | 679 | 3.0% | 0 | 25 |
Other Indications for ALIROCUMAB
Hyperlipidaemia (3,317)
Blood cholesterol increased (2,246)
Type iia hyperlipidaemia (1,913)
Product used for unknown indication (1,704)
Blood cholesterol (1,299)
Type v hyperlipidaemia (902)
Arteriosclerosis (417)
Blood cholesterol abnormal (345)
Low density lipoprotein increased (326)
Arteriosclerosis coronary artery (145)
Other Drugs Used for Hypercholesterolaemia
EVOLOCUMAB (23,505)
ATORVASTATIN (5,615)
SIMVASTATIN (3,010)
ROSUVASTATIN (2,690)
EZETIMIBE (1,589)
PRAVASTATIN (764)
INCLISIRAN (486)
FENOFIBRATE (286)
FLUVASTATIN (264)
BEMPEDOIC ACID (228)